"Researchers are making progress toward understanding how some cases of glaucoma begin. A new study from the National Eye Institute reveals that myocilin—a protein linked to a significant fraction of glaucoma—is needed to insulate peri"...
- Patient Information:
Details with Side Effects
VIGAMOX® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
Streptococcus viridans group
Haemophilus parainfluenzae *
*Efficacy for this organism was studied in fewer than 10 infections.
Dosage Forms and Strengths
4 mL bottle filled with 3 mL sterile ophthalmic solution of moxifloxacin hydrochloride, 0.5% as base.
VIGAMOX® solution is supplied as a sterile ophthalmic solution in Alcon's DROP-TAINER® dispensing system consisting of a natural low density polyethylene bottle and dispensing plug and tan polypropylene closure. Tamper evidence is provided with a shrink band around the closure and neck area of the package.
3 mL in a 4 mL bottle - NDC 0065-4013-03
Storage: Store at 2°C- 25°C (36°F - 77°F).
Manufactured by Alcon Laboratories, Inc. Fort Worth, TX 76134 USA. Licensed to Alcon, Inc. by Bayer Schering Pharma AG.
Last reviewed on RxList: 10/24/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Vigamox Information
Vigamox - User Reviews
Vigamox User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Get breaking medical news.